High Burden of Deep-Seated Plexiform Neurofibromas (PN) in Children with Neurofibromatosis 1 (NF1): Image-Defined Risk Factors

被引：0
|
作者：
Kelaidi, C. [1 ]
Petrikkos, L. [1 ]
Tzotzola, V. S. [1 ]
Antoniadi, K. [1 ]
Gavra, M. [2 ]
Stefanaki, K. [3 ]
Polychronopoulou, S. [1 ]
机构：
[1] Aghia Sophia Childrens Hosp, Dept Pediat Hematol & Oncol, Athens, Greece
[2] Aghia Sophia Childrens Hosp, Dept Radiol, Athens, Greece
[3] Aghia Sophia Childrens Hosp, Dept Pathol, Athens, Greece
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V395 SIOP1
引用
下载
收藏
页码：S355 / S355
页数：1
相关论文
共 50 条
  • [1] PHASE I TRIAL OF SORAFENIB IN CHILDREN WITH NEUROFIBROMATOSIS TYPE I (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN)
    Kim, A.
    Dombi, E.
    Tepas, K.
    Fox, E.
    Balis, F. M.
    Korf, B.
    Widemann, B. C.
    NEURO-ONCOLOGY, 2010, 12 (06) : II42 - II42
  • [2] Association of superficial plexiform and paraspinal neurofibromas in neurofibromatosis 1 (NF1)
    Baser, ME
    Birch, PH
    Evans, DGR
    Friedman, JM
    NEUROLOGY, 1999, 52 (07) : 1519 - 1520
  • [3] Surgical Treatment and Complications of Deep-Seated Nodular Plexiform Neurofibromas Associated with Neurofibromatosis Type 1
    Ikuta, Kunihiro
    Nishida, Yoshihiro
    Sakai, Tomohisa
    Koike, Hiroshi
    Ito, Kan
    Urakawa, Hiroshi
    Imagama, Shiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [4] PLEXIFORM NEUROFIBROMAS IN NEUROFIBROMATOSIS TYPE-1 (NF1) - THE OUTCOME OF SURGERY
    SUJANSKY, E
    CONRADI, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 278 - 278
  • [5] Association of superficial plexiform and paraspinal neurofibromas in neurofibromatosis 1 (NF1) - Reply
    Tonsgard, JH
    NEUROLOGY, 1999, 52 (07) : 1520 - 1520
  • [6] Somatic loss of the NF1 gene in plexiform neurofibromas in neurofibromatosis type 1.
    Rasmussen, SA
    Colman, SD
    Abernathy, CR
    Muir, D
    Wallace, MR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A80 - A80
  • [7] PREDICTORS OF PLEXIFORM NEUROFIBROMA (PN) GROWTH IN PATIENTS WITH NEUROFIBROMATOSIS 1 (NF1)
    Akshintala, Srivandana
    Dombi, Eva
    Baldwin, Andrea
    Gillespie, Andy
    Goodspeed, Wendy
    Goodwin, Anne
    Whitcomb, Patricia
    Steinberg, Seth
    Widemann, Brigitte
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S32 - S33
  • [8] TRAMETINIB FOR ORBITAL PLEXIFORM NEUROFIBROMAS IN YOUNG CHILDREN WITH NF1
    Toledano, Helen
    Dotan, Gad
    Friedland, Rivka
    Cohen, Rony
    Yassur, Iftach
    Toledano, Hagit
    Constantini, Shlomi
    Rootman, Mika Shapira
    NEURO-ONCOLOGY, 2020, 22 : 418 - 418
  • [9] CLINICAL BURDEN AMONG PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES (US)
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy
    Sipsma, Heather
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei Sheng
    NEURO-ONCOLOGY, 2021, 23 : 41 - 42
  • [10] Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN).
    Geoerger, Birgit
    Moertel, Christopher L.
    Whitlock, James
    McCowage, Geoffrey Brian
    Kieran, Mark W.
    Broniscer, Alberto
    Hargrave, Darren R.
    Hingorani, Pooja
    Kilburn, Lindsay Baker
    Mueller, Sabine
    Tseng, Lillian
    Nebot, Noelia
    Dasgupta, Kohinoor
    Russo, Mark W.
    Fox, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345